Magnesium Sulfate Pediatric Dose — Electrolyte Replacement
Magnesium sulfate is an essential mineral and electrolyte replacement agent that replenishes intracellular magnesium stores by providing exogenous magnesium ions. It is used in pediatric patients to treat hypomagnesemia, which may arise in the setting of malnutrition, prolonged diuretic use, gastrointestinal losses, or critical illness. Adequate magnesium levels are important for neuromuscular function, cardiac rhythm stability, and enzymatic processes throughout the body.
Pediatric Dosing
For electrolyte replacement in pediatric patients, the recommended dose of magnesium sulfate is 25–50 mg/kg IV, administered over 2 hours. The maximum single dose is 2 g regardless of weight.
- Dose: 25–50 mg/kg IV per dose
- Route: Intravenous (IV)
- Infusion duration: Over 2 hours
- Maximum dose: 2 g per dose
Worked example: For a 20 kg child at 50 mg/kg: 20 × 50 mg/kg = 1,000 mg (1 g) total. For a 50 kg adolescent at 50 mg/kg: 50 × 50 mg = 2,500 mg — capped at the maximum of 2 g per dose.
Indications and Clinical Context
Magnesium sulfate IV replacement is indicated in pediatric patients with documented or clinically suspected hypomagnesemia. Common clinical scenarios include patients in the PICU with prolonged nasogastric losses, those receiving loop or thiazide diuretics, critically ill children with poor oral intake, or patients undergoing parenteral nutrition optimization. Symptomatic hypomagnesemia may manifest as muscle weakness, tremor, tetany, or cardiac dysrhythmias, warranting prompt intravenous correction.
Electrolyte replacement with magnesium sulfate falls within the broader category of supportive critical care and general pediatric management. Dosing should be guided by serum magnesium levels when available, and repeat dosing or continuous infusion strategies should follow institutional protocols and the clinical response of the patient.
Administration and Monitoring
Magnesium sulfate must be administered intravenously and infused slowly over 2 hours to minimize the risk of adverse effects associated with rapid infusion, including flushing, hypotension, and bradycardia. Bolus or rapid IV push administration is not appropriate for electrolyte replacement dosing. Ensure peripheral or central IV access is patent prior to infusion; consult institutional protocol regarding concentration limits for peripheral lines.
- Route: IV only for this indication
- Infusion rate: Administer over 2 hours
- Maximum single dose: 2 g — doses calculated to exceed this must be capped
- Monitor: Heart rate, blood pressure, respiratory rate, and deep tendon reflexes during infusion
- Adverse effects: Flushing, hypotension, bradycardia, respiratory depression (particularly at higher or rapid doses)
- Caution: Use with care in patients with renal impairment, as magnesium is renally cleared; consult institutional protocol for dose adjustment
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.